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Abstract 
An original serie of 12- to 22-residue-long peptides was developed, they are only constituted by apolar Leu and charged Lys residues periodically 
located in the sequence in order to generate ideal highly amphipathic a-he&s. By circular dichroism, the peptides are proven to be mainly a-helical 
in organic and aqueous olvents and in the presence of lipids. The peptides are highly hemolytic, their activity varies according to the peptide length. 
The IS-, 20-, and 22-residue-long-peptides have LD,, - 5 x lo-’ M for IO’erythrocytes, i.e. they are 5-10 times more active than melittin, and are indeed 
several orders of magnitude more active than magainin or mastoparan. 
Key words: Amphipathic helix; Hemolysis; Cytotoxic peptide 
1. Introduction 
Cytotoxic amphipathic peptides represent a wide vari- 
ety of natural compounds secreted by living cells; they 
are generally basic. Melittin (Mel), the best known with 
the highest hemolytic activity, comes from bee venom. It 
has a 26-amino acid residue-long sequence with a charac- 
teristic cluster of Lys and Arg residues at the COO-termi- 
nus which is required for activity [1,2]. S-Hemolysin from 
Staphylococcus aureus behaves similarly although it is 
more polar and has no net charge at pH 7.5 [2,3]. 
Magainins, 23-residue-long peptides from frog skin, are 
essentially toxic for bacterial strains while being poorly 
hemolytic [2,4]. Bombolitins, mastoparans and related 
peptides are shorter, down to 14 residues. They are gen- 
erally weakly hemolytic despite having cytotoxic proper- 
ties [2]. Numerous studies have been performed to under- 
stand structure-function relationships; while only few 
have been devoted to rationalizing their sequences and 
to generating new more active peptides. In a pioneering 
work, De Grado et al. first simplified the Mel sequence 
creating an analog with an ideal amphipathic a-helical 
sequence from position 1 to 19 followed by the 20-26 
natural segment [5]. This led to a more active peptide 
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Abbreviations: L&, peptide composed of i residues Leu and j residues 
Lys; Dns, dansyl; Mel, melittin; Lyso-PC, lysophosphatidylcholine; 
DMPC, dimyristoyl phosphatidylcholine; WV, small unilamellar vesi- 
cles; Ha, a-helix. 
which proves that the kink in the a-helix is not required 
for hemolytic activity [5,6]. More recently, Mel hybrids 
with reversed sequence (1626) (1-13) showed no hemo- 
lytic activity despite the fact that they remain anti- 
bacterial [7]. The synthesis of more than 50 analogs with 
systematic substitutions by Leu or single residue deletion 
proved that some residues play an essential role, e.g. 
Lys,, Trp,,, and confirmed that a large a-helical am- 
phipathicity is the main requirement for activity [&IO]. 
In this work we speculate that an ideally amphipathic 
a-helix with positively charged residues periodically lo- 
cated all along the peptide chain should have an activity 
similar to that of Mel. Such a de novo synthesis has 
already proved successful to mimic hormones or cahnod- 
ulin-binding peptides [I 11. In this work we associated the 
strongly apolar and helix-forming Leu residue to the 
basic one, Lys, which is the more frequent in the natural 
cytotoxins. Instead of using a 1: 1 Leu-toLys ratio to 
generate highly polar and charged peptides, as recently 
studeid [12], we selected a 2:l ratio. This allowed us to 
generate peptides of about the same size and charge as 
the natural toxins, more hydrophobic than those already 
studied in literature. 
Here we document he hemolytic activity and the spec- 
troscopic properties of a series of peptides whose lengths 
varied from 12 to 22 residues. 
2. Materials and methods 
2.1. Peptide synthesis 
Seven peptides, 12-22-residues-long, were synthesized by SPM, using 
the base labile Fmoc-protecting roup for the a-amino-terminus and 
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TFA-cleavable protecting groups for the various functionalities of the 
amino acid side chains. The chain assembly was performed on an 
automated peptide synthesizer (ABI, model 43OA). The synthesis was 
developed by resin splitting, removing parts of the resin at respective 
positions and continuing with the rest. At the end of the syntheses the 
N,,,Fmoc groups are removed and the resulting free amino groups are 
reacted with a ten-fold excess of dansyl chloride in NMP. After comple- 
tion, the peptides were cleaved from the resin using a mixture of TFA/ 
AnisoUwater (90% :5% : 5%). Peptides were purified by HPLC on a CN 
column (M&N) operated in the reverse phase mode, using a gradient 
of 35% to 100% CHrCN. The single peak eluting peptides have reten- 
tion times determined on an analytical CN column (M&N, ET250814 
Nucleosil 300-7 CN), which increase from 21 to 24.4 and 27.7 min for 
the 12-, 15- and 22-residue-long peptides. The peptides’ compositions 
were checked on an amino acid analyzer (ABI, model 420A) and their 
sequences were confirmed on an ABI model 477A before reacting the 
peptides with dansyl chloride. The mass (Finnigan MAT, model 
TSQ700/ESI) of the 1Zmer is in good agreement with the theoretical 
one (MW,,, = 1669.0 g.mol-’ vs. MWLhcor = 1669.9 g.moll’). The pu- 
rity of all peptides is > 95% based on HPLC, they are all soluble in 
MeOH and their concentrations were estimated using the molar extinc- 
tion coefficient of the dansyl group, .srZO nm = 4640 M-’ . cm-‘. 
2.2. Hemolytic assay 
Fresh human blood from a healthy 0’ donor was collected on citrate 
and centrifuged 3 min at 980 x g. The erythrocyte pellet was washed 
several times and finally resuspended in 20 mM Tris, 130 mM NaCl 
buffer, pH 7.5. For each assay, peptides were diluted at the defined 
concentration in 1 ml of buffer, then 0.5 ml of the stock solution of 
diluted cells were added corresponding to 10’ cells/assay in all experi- 
ments. The mixture is incubated at 37°C for 2 h and the % of hemolysis 
is defined by measuring the absorbance at 414 nm of the supematant 
after pelleting ghosts and undamaged cells for 3 min at 1000 x g. The 
0% hemolysis is obtained incubating erythrocytes with isotonic buffer 
alone while the 100% hemolysis is found in pure water. The data 
reported are generally a mean of two or three independent measure- 
ments. 
2.3. Spectroscopic measurements 
Absorption spectra were routinely recorded with a Pye Unicam Phil- 
ips spectrometer 8800. Far UV dichroic absorption spectra were re- 
corded on an AVIV 62DS spectrometer in thermostated 0.1 or 1 cm 
cuvettes, respectively, for low and high peptide concentrations. The 
reported data are the mean of at least 3 independent measurements. 
Backgrounds were always substracted. 
2.4. Materials 
The phospholipids used were from Lipid Products (Nutfield, UK) 
and Avanti Polar Lipids (Birmingham, USA). The lyophylized powder 
is hydrated in Tris 20 mM, pH 7.5, buffer, homogeneized on a vortex 
and bath sonicated for 2 min until obtaining homogeneously scattering 
solutions at 5 mg/ml which mainly consist of SUVs. Melittin was pur- 
chased from Serva, synthetic magainin II from Neosystem (France) and 
poliste mastoparan from Peninsula Laboratories (USA). 
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3. Results and discussion 
3. I. Peptide design and amphipaticity 
The primary structure of the peptides synthesized are 
summarized in Table 1. The 22-residue-long peptide con- 
stitutes the parent sequence, the shorter ones correspond 
to increased shortenings from the N,,, side. The 
N-terminus is blocked by the dansyl group. 
The design of these sequences used minimal require- 
ments to generate highly amphipathic peptides when 
folded in a-helix. The roughly 2 : 1 molar ratio of Leu-to- 
Lys allows peptides in the range of 20-mers to be ob- 
tained. These peptides have a net charge and an hydro- 
phobic sector not very different from that of Mel [2] 
despite the fact that there is no relation at all in the 
sequences or in the charge topology. 
When folded in an a-helix, such sequences generate 
highly amphipathic peptides. This is shown by the 
Edmundson wheels for the shortest and longest peptides 
(Fig. 1). All the peptides fold in such a way that all Lys 
are confined within a sector of about a 100” width re- 
gardless of chain length. This corresponds to what oc- 
curs in cytotoxins [14]. Using the Eisenberg’s hydropho- 
bic scale and moment method [13], these LiKj peptides 
have an hydrophobic moment per residue 
c ,uUH > = 0.43 + 0.03. Such a value is quite higher than 
those calculated not only for the LiKi serie previously 
described by Blondelle [12], < ,uH > = 0.29, but also for 
1-21 Mel, <pH > = 0.28, and even for &toxin, 
< pH > = 0.38. Indeed the total hydrophobic moment of 
the peptides, pH, increases linearly with their lengths 
frompu, = 5.1 for the shorter 12-mer up to ,uUH = 9.8 for 
the larger one. Such values are larger than that estimated 
for the 1-21 fragment of Mel, pH = 6, and compare to 
that of the 26-residue-long amphipathic rod of J-toxin 
j&r = 9.87. 
3.2. Secondary structure of the peptides 
In buffer or methanol solutions the far UV dichroic 
spectra show that the longer the peptide the higher the 
absolute values for their dichroic absorbance at extrema 
Table 1 
Definition and sequences of the studied peptides 
Peptide Composition Sequences 
length 
1 4 8 11 15 19 22 
22 L,5K, Dns K L L K LL L KL L K LLLK LLLK LLK 
21 L&6 Dns L L K LL L KL L K LLLK LLLK LLK 
20 L,,K, Dns L K LL L KL L K LLLK LLLK LLK 
19 L,rK, Dns K LL L KL L K LLLK LLLK LLK 
18 L,gK, DnsLL L KL L K LLLK LLLK LLK 
15 L,,Ks DnsKL L K LLLK LLLK LLK 
12 LsK4 DnsK LLLK LLLK LLK 
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Fig. 1. Helical wheel representation of model peptides. Left: L&; right: L,,K,, for a better comp(arison the amino acid numeration is the one used 
for the longest peptide. 
(Fig. 2). The spectra are characteristic of what is ex- 
pected for mainly cc-helical structures (Fig. 2). The char- 
acteristic value at 222 nm decreases progressively, from 
0,,, = - 14,800 deg .cm’.dmol-’ for L&, down to 
I9 222 = -35,000 deg. cm2 a dmol-’ for the 22-residue-long 
peptide. For this last compound, the whole spectrum 
from 190 to 340 nm, can also be fitted with that of a pure 
a-helical structure. 
When Lyso PC or DMPC vesicles are added to the 
peptides in buffer solution at 30°C significant changes 
in the CD spectra are observed. At high lipid-to-peptide 
molar ratios ( 2 100) characteristic absolute values of 
8,95 and 8222 are increased, as seen in Fig. 3a,b, indicating 
an increase in the a-helix content. In DMPC only the 
shorter L,K, has a low a-helix content ( -40%) LloKs like 
L,& are about 80% a-helix, the longest L,SK, account- 
ing for 100% cc-helix. 
Direct use of CD proteins data to fit spectra or analyze 
0222 values of short peptides in terms of a-helix content 
can be questioned since the characteristic dichroic values 
of each type of structure depend on the number of the 
L I 
190 200 210 220 230 240 250 260 
Wavelength (nm) 
Fig. 2. CD spectra of the studied peptides in aqueous solution (Tris 1 
mM, pH = 7.5) peptide concentration: 5pM. 1 = DNS LISK,; 2 = DNS 
L,,&; 3 = DNS L,,KS; 4 = DNS L,K.,; 5 = Mel. 
residues involved [15]. In Fig. 3 the data from LiKj pep- 
tides compare quite well to those of highly favoured 
a-helical peptides [ 161. Moreover, the concomitant 
changes of B,,, and eZ2 values when the LiKj peptide 
length increases are coherent to what was expected from 
theoretical and statistical calculations [15,171. Such gen- 
eral agreement allows us to conclude that the longer 
peptides when bound to lipids behave essentially as pure 
a-helices while the shorter ones, 12- and 15-mers, adopt 
significantly the same &-helical structure. A CD study 
versus temperature (data not shown) strengthens uch 
conclusions that the longer the peptides the more stable 
their structure. 
3.3. Hemolytic activity of the LiKj peptides 
The synthesized peptides were assayed for hemolysis 
of human red blood cells and dose-response curves are 
shown on Fig. 4. The 20- and 22-mer peptides display an 
activity in the nanomolar range with an LD,, value -4 
6 x 10e8 M. In identical experimental conditions Mel 
used as a reference has an LD,, = 0.40.5 ,uM, i.e. the 
peptides synthesized herein are about 610 times more 
active. Shortening the peptides decreases the hemolytic 
activity: the 19-mers has an LD,, = 2.1 PM and the 18- 
mers LD,, increases up to 4.7 PM, i.e. about 80 times 
larger than that of the 22-mers. However, decreasing the 
peptide length further, a high activity is found again for 
the L,,,K5, LDsO = 0.1 ,uM, while the shorter L8K4 pep- 
tide remains as active as the 18-mers. Even though the 
Dns group favors the activity, the 22-mer L,,K, with the 
free N-terminus remains three times more active than 
Mel, LD,, = 0.16 PM (data not shown). 
The hemolytic activities found herein are indeed much 
larger compared to those of the naturally occurring cy- 
tolytic peptides. This is true for Mel (Fig. 4) and it is 
even much more drastic when compared to the barely 
active magainin, and the shorter mastoparan which only 
gave significant hemolysis ( 2 10%) at high concentra- 
tion ( 2 10 PM). 
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Fig. 3. Changes in the molar ellipticity per residue at 222 nm (a) and 195 nm (b) versus the peptidic chain length in different conditions. (0) peptides 
in buffer at 5 PM; (m) peptides in MeOH at 50 ,uM; (0) peptides bound to lysolecithin micelles, PWpept = 100; [Peptide] = 5 PM; (---) calculated 
laws by Chen et al. [15]; (-) and Katakai et al. [16]; (A) data from Manning et al. [17] for (MML), peptides in apolar medium. 
4. Discussion and conclusion 
The extreme reductionism to generate amphipathic 
peptides with only Leu and Lys residues, periodically 
located along the sequence, leads to compounds which 
are proven to be an a-helix, particularly when bound to 
lipids. Peptides have a very highly hemolytic activity, up 
to 5-10 times that of Mel for 15-, 20-, 21- and 22-residue- 
long peptides. 
Therefore, a highly sophisticated sequence with nu- 
merous different, more or less polar, residues is not re- 
quired to get hemolytic activity. The unique concept of 
generating an ideally amphipathic a-helical rod with 
apolar and charged residues properly located periodi- 
cally at each turn is sufficient to fulfill the requirements 
to get the strongest hemolytic peptides. 
Two recent attempts to get hemolytic model peptides 
were developed. First, Blondelle and Houghton [12] syn- 
thesized peptides with a Leu/Lys ratio = 1 and Tytler et 
al. [18] proposed an 18-residue-long peptide to be the 
archetype for lytic peptides. However, in both studies 
authors did not provide structural data: they only meas- 
ured a high amount of lysis ( = 80%) at two peptide 
concentrations (43 PM and 3 yM). Since they used about 
a ten-fold higher cell concentration compared to that 
used in our experiments, one can roughly estimate the 
18-L-consensus peptide [18] has an hemolytic activity 
about three-fold higher than the one of melittin, close to 
that of our 22-mer with free N-terminus. However, the 
activities of LiKi peptides are 4-7 times lower than that 
of Mel, e.g. about 50 times less active compared to the 
most active peptides studied herein. 
The apolar cluster constituted by 8 Leu residues like 
in the 12-mer allow the high partitioning into lipids re- 
quired for activity. The real need for highly charged 
0 0.02 0.05 0.1 0.2 0.5 1 -2 5 10 
peptide concekmtion in micrwnolar 
Fig. 4. Hemolysis induced by the amphipathic peptides on 10’ cells/ml 
at 37°C Tris buffer 20 mM, 130 mM NaCl, pH 7.5. Natural cytotoxins: 
(+) Mel; (r) Magainin; (0) Mastoparan. Synthetic dansylated peptides 
of increasing length: (0) 12-; (x) 15-; (0) 1%; (c) 19-; (V) 20-; (0) 21-; 
(m) 22-mers. 
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peptides has not been properly understood until now. 
Charges allow peptide solubility and prevent a massive 
aggregation in water. Moreover, they can play a role in 
binding to membranes. The charge topology herein to- 
tally differs from that of Mel but is rather similar to that 
of other amphipathic peptides remaining more probably 
flat on the bilayer [19,20]. 
Taking into account the amphipathic concept, a mo- 
notonous increase in activity was expected versus the 
peptide length, a threshold being anticipated from the 
study of d-toxin analogues [3]. This is not what is ob- 
served since a maximum of the activity of 15-residue- 
long peptide is followed by a drop of the hemolytic activ- 
ity for 18- and 19-residue-long-ones. This dual behavior 
could be related to the self-association of peptides in 
solution, which should increase in parallel with the pep- 
tide length and would decrease peptide activity. 
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